Related references
Note: Only part of the references are listed.Prognostic value of innate and adaptive immunity in colorectal cancer
Fabio Grizzi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Optimal Colorectal Cancer Staging Criteria in TNM Classification
Hideki Ueno et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Molecular staging individualizing cancer management
Alex Mejia et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Cancer classification using the Immunoscore: a worldwide task force
Jerome Galon et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Aspirin as adjuvant therapy for colorectal cancer-reinterpreting paradigms
Whay Kuang Chia et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Xiaoyun Liao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
Niels Halama et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory Drugs
Andrew T. Chan et al.
GASTROENTEROLOGY (2011)
Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
Erin S. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinicopathological staging of colorectal cancer: Evolution and consensus-an Australian perspective
Pierre H. Chapuis et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
Frank A. Sinicrope et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
Anna M. Dahlin et al.
MODERN PATHOLOGY (2011)
Cancer immunology-analysis of host and tumor factors for personalized medicine
Shuji Ogino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ- and JNK1-Dependent Inflammation
Hiroyuki Takahashi et al.
CANCER CELL (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
Katsuhiko Nosho et al.
JOURNAL OF PATHOLOGY (2010)
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
Rosaria Cammarota et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Oncogenic mutations as predictive factors in colorectal cancer
A. Lievre et al.
ONCOGENE (2010)
Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth
Kei Sakamoto et al.
CLINICAL CANCER RESEARCH (2009)
Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2009)
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Bharat B. Aggarwal et al.
CLINICAL CANCER RESEARCH (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CD3+cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
Luigi Laghi et al.
LANCET ONCOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy
Melinda Morris et al.
CLINICAL CANCER RESEARCH (2008)
Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies
Imke Atreya et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Tumour immunity: effector response to tumour and role of the microenvironment
Alberto Mantovani et al.
LANCET (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature
Daniel G. Nicastri et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer
Imke Atreya et al.
GUT (2007)
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
Vassilis Golfinopoulos et al.
LANCET ONCOLOGY (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer
Alberto Malesci et al.
CLINICAL CANCER RESEARCH (2007)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
Tumor infiltrating T lymphocytes in colorectal cancer -: Tumor-selective activation and cytotoxic activity in situ
Moritz Koch et al.
ANNALS OF SURGERY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
C Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Chronic inflammation: A common and important factor in the pathogenesis of neoplasia
D Schottenfeld et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Serrated adenomas have a pattern of genetic alterations that distinguishes them from other colorectal polyps
M Yashiro et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer
AT Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
P Correale et al.
JOURNAL OF IMMUNOLOGY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Prognostic role of CD8+tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability
F Prall et al.
HUMAN PATHOLOGY (2004)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery
RM MacKie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer
D Schrag et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
R Gryfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Infections as a major preventable cause of human cancer
H Kuper et al.
JOURNAL OF INTERNAL MEDICINE (2000)
Share Paper
